Ribavirin
6 NDCs across 1 manufacturer|6 Generic,0 Brand
Ribavirin is used to treat human adenovirus infections, chronic hepatitis c, respiratory syncytial virus infections and west nile fever, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 31, 1985, and the first generic was approved Apr 6, 2004. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $246K on Ribavirin across 1,989 claims for 1,128 beneficiaries.
Ribavirin is available as 6 NDCs from 1 manufacturer (6 generic, 0 brand), with NADAC prices from $0.45 to $1.28 per EA — the most expensive product costs about 2.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
6G / 0B
Manufacturers
1
competing in market
Price Spread
$0.45 – $1.28
per EA
7d Activity
avg +0.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nucleoside Analog Antiviral class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing RIBAVIRIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RIBAVIRIN 200 MG CAPSULE | $1.2755 per EA | — |
RIBAVIRIN 200 MG CAPSULE | $1.2755 per EA | — |
RIBAVIRIN 200 MG CAPSULE | $1.2755 per EA | — |
RIBAVIRIN 200 MG CAPSULE | $1.2755 per EA | — |
RIBAVIRIN 200 MG CAPSULE | $1.2755 per EA | — |
RIBAVIRIN 200 MG TABLET | $0.4507 per EA | — |
Frequently Asked Questions
What is Ribavirin used to treat?
Ribavirin is used to treat human adenovirus infections, chronic hepatitis c, respiratory syncytial virus infections and west nile fever, per the National Library of Medicine's MED-RT classification.
When did Ribavirin become available as a generic?
FDA approved the first generic Ribavirin (ANDA) on Apr 6, 2004. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ribavirin?
In 2024, Medicare Part D spent $246K on Ribavirin across 1,989 claims for 1,128 beneficiaries.
How many Ribavirin products are on the market?
The Ribavirin drug market contains 6 NDCs from 1 manufacturer — 6 generic and 0 brand products.
What is the price range for Ribavirin?
NADAC reference prices for Ribavirin range from $0.4507 to $1.2755 per EA — the most expensive product costs about 2.8× the cheapest.
Which manufacturers make Ribavirin?
1 manufacturer lists Ribavirin in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (6).